These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35922959)

  • 1. Predictors of long-term medication adherence in stroke survivors: A multicentre, prospective, longitudinal study.
    Yoo SH; Kim GG; Kim SR; Park MS; Kim JT; Choi KH; Park HY; Yi SH; Cha JK; Kim DH; Nah HW
    J Clin Nurs; 2023 Jan; 32(1-2):58-70. PubMed ID: 35922959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Influencing 1-Year Medication Adherence of Korean Ischemic Stroke Survivors.
    Kim GG; Chae DH; Park MS; Yoo SH
    Int J Behav Med; 2020 Apr; 27(2):225-234. PubMed ID: 32026290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary preventive medication persistence and adherence 1 year after stroke.
    Bushnell CD; Olson DM; Zhao X; Pan W; Zimmer LO; Goldstein LB; Alberts MJ; Fagan SC; Fonarow GC; Johnston SC; Kidwell C; Labresh KA; Ovbiagele B; Schwamm L; Peterson ED;
    Neurology; 2011 Sep; 77(12):1182-90. PubMed ID: 21900638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of adherence to secondary preventive medication in stroke patients.
    O'Carroll R; Whittaker J; Hamilton B; Johnston M; Sudlow C; Dennis M
    Ann Behav Med; 2011 Jun; 41(3):383-90. PubMed ID: 21193977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent predictors of medication adherence among Singaporean patients following an ischaemic stroke or transient ischaemic attack.
    Wang W; Chia GS; Tan IF; Tye SNJ; Wang X; Zhu B; Jiang Y
    J Clin Nurs; 2017 Dec; 26(23-24):5016-5024. PubMed ID: 28793375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key barriers to medication adherence in survivors of strokes and transient ischemic attacks.
    Kronish IM; Diefenbach MA; Edmondson DE; Phillips LA; Fei K; Horowitz CR
    J Gen Intern Med; 2013 May; 28(5):675-82. PubMed ID: 23288379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifiable Factors Associated with Non-Adherence to Secondary Ischaemic Stroke Prevention Strategies.
    Shankari G; Ng SC; Goh SY; Woon FP; Doshi K; Wong PS; Fan Q; Tan IF; Narasimhalu K; De Silva DA
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105395. PubMed ID: 33254378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
    Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
    Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum.
    Jamison J; Sutton S; Mant J; De Simoni A
    BMJ Open; 2017 Jul; 7(7):e016814. PubMed ID: 28713074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care.
    Jamison J; Graffy J; Mullis R; Mant J; Sutton S
    Br J Gen Pract; 2016 Aug; 66(649):e568-76. PubMed ID: 27215572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication-taking after stroke: a qualitative meta-synthesis of the perspectives of stroke survivors, informal carers and health professionals.
    Gibson JME; Miller C; Coupe J; Jones SP
    Fam Pract; 2020 Feb; 37(1):4-14. PubMed ID: 31324915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke.
    Thrift AG; Kim J; Douzmanian V; Gall SL; Arabshahi S; Loh M; Evans RG
    Stroke; 2014 Feb; 45(2):539-44. PubMed ID: 24335222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiprofessional intervention to improve adherence to medication in stroke patients: a study protocol for a randomised controlled trial (ADMED AVC study).
    Khettar S; Jacquin Courtois S; Luaute J; Decullier E; Bin S; Dupuis M; Derex L; Mechtouff L; Nighoghossian N; Dussart C; Rode G; Janoly-Dumenil A
    Eur J Hosp Pharm; 2022 May; 29(3):169-175. PubMed ID: 32978218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP; Sander S; Shah H; Zarotsky V; Henk H
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessment.
    Murphy SJ; Coughlan CA; Tobin O; Kinsella J; Lonergan R; Gutkin M; McCabe DJ
    J Neurol Sci; 2016 Feb; 361():13-8. PubMed ID: 26810509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Related to Beliefs about Medication in Ischemic Stroke Patients.
    Kim GG; Yoo SH; Park MS; Park HY; Cha JK
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of beliefs about medication on the relationship between trust in physician with medication adherence after stroke.
    Fan Q; Doshi K; Narasimhalu K; Shankari G; Wong PS; Tan IF; Ng SC; Goh SY; Woon FP; De Silva DA
    Patient Educ Couns; 2022 Apr; 105(4):1025-1029. PubMed ID: 34281721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in persistence to secondary prevention medication regimens after ischemic stroke.
    Sheehan OC; Dhamoon MS; Bettger JP; Huang J; Liu C; Rhodes JD; Clay OJ; Roth DL
    Ethn Health; 2022 Oct; 27(7):1671-1683. PubMed ID: 34196573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns about medications mediate the association of posttraumatic stress disorder with adherence to medication in stroke survivors.
    Edmondson D; Horowitz CR; Goldfinger JZ; Fei K; Kronish IM
    Br J Health Psychol; 2013 Nov; 18(4):799-813. PubMed ID: 23294320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack.
    Zhang L; Shi J; Pan Y; Li Z; Yan H; Liu C; Lv W; Meng X; Wang Y
    Stroke Vasc Neurol; 2021 Sep; 6(3):376-383. PubMed ID: 33526631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.